OpenBilldrug price receipt

NADAC week of 2026-10-14

DEXMETHYLPHENIDATE ER 35 MG CP

For 30 capsules

Pharmacies pay

$62.15 filed

30 × $2.07153 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$82.24 filed

30 × $2.74149 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

1.3× estimated

Medicare paid 1.3× what pharmacies pay.

Part D averages every strength and form sold under “Dexmethylphenidate HCl ER” / “Dexmethylphenidate HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$76.47 estimated

$62.15 + $9.32 (15%) + $5.00 fee per fill = $76.47

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

DEXMETHYLPHENIDATE ER 35 MG CP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as dexmethylphenidate hydrochloride, under the trade name “Dexmethylphenidate Hydrochloride Extended-Release”.

FDA gives its dosage form as capsule, extended release and its route as oral.

FDA lists 6 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Amneal Pharmaceuticals of New York LLC and Lannett Company, Inc.

FDA’s Established Pharmacologic Class for it is Central Nervous System Stimulant.

The NADAC file of 2026-10-14 prices it under 6 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $62.15 for 30 capsules (30 × $2.07153 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

All 6 NDCs

Other strengths, forms and brands

21 other products in the NADAC file share the FDA nonproprietary name dexmethylphenidate hydrochloride with DEXMETHYLPHENIDATE ER 35 MG CP.

ProductPharmacies pay per unitMedicare per unit
DEXMETHYLPHENIDATE 2.5 MG TAB
generic · tablet
$0.19002 per EA filed
eff. 2026-09-23
$0.50453 per EA filed
Part D 2024 average
DEXMETHYLPHENIDATE 5 MG TAB
generic · tablet
$0.26984 per EA filed
eff. 2026-09-23
$0.50453 per EA filed
Part D 2024 average
DEXMETHYLPHENIDATE 10 MG TAB
generic · tablet
$0.34138 per EA filed
eff. 2026-09-23
$0.50453 per EA filed
Part D 2024 average
DEXMETHYLPHENIDATE ER 5 MG CAP
generic · capsule, extended release
$1.01375 per EA filed
eff. 2026-09-23
$2.74149 per EA filed
Part D 2024 average
DEXMETHYLPHENIDATE ER 10 MG CP
generic · capsule, extended release
$1.45204 per EA filed
eff. 2026-09-23
$2.74149 per EA filed
Part D 2024 average
DEXMETHYLPHENIDATE ER 15 MG CP
generic · capsule, extended release
$0.79814 per EA filed
eff. 2026-09-23
$2.74149 per EA filed
Part D 2024 average
DEXMETHYLPHENIDATE ER 20 MG CP
generic · capsule, extended release
$1.6924 per EA filed
eff. 2026-09-23
$2.74149 per EA filed
Part D 2024 average
DEXMETHYLPHENIDATE ER 25 MG CP
generic · capsule, extended release
$1.75805 per EA filed
eff. 2026-09-23
$2.74149 per EA filed
Part D 2024 average
DEXMETHYLPHENIDATE ER 30 MG CP
generic · capsule, extended release
$1.55941 per EA filed
eff. 2026-09-23
$2.74149 per EA filed
Part D 2024 average
DEXMETHYLPHENIDATE ER 35 MG CP this page
generic · capsule, extended release
$2.07153 per EA filed
eff. 2026-09-23
$2.74149 per EA filed
Part D 2024 average
DEXMETHYLPHENIDATE ER 40 MG CP
generic · capsule, extended release
$1.65667 per EA filed
eff. 2026-09-23
$2.74149 per EA filed
Part D 2024 average
FOCALIN 2.5 MG TABLET
brand · tablet
$0.64992 per EA filed
eff. 2026-05-20
$1.24103 per EA filed
Part D 2024 average
FOCALIN 5 MG TABLET
brand · tablet
$0.92343 per EA filed
eff. 2026-09-23
$1.24103 per EA filed
Part D 2024 average
FOCALIN 10 MG TABLET
brand · tablet
$1.32932 per EA filed
eff. 2026-09-23
$1.24103 per EA filed
Part D 2024 average
FOCALIN XR 5 MG CAPSULE
brand · capsule, extended release
$4.70352 per EA filed
eff. 2026-09-23
$7.64418 per EA filed
Part D 2024 average
FOCALIN XR 10 MG CAPSULE
brand · capsule, extended release
$4.76073 per EA filed
eff. 2026-09-23
$7.64418 per EA filed
Part D 2024 average
FOCALIN XR 15 MG CAPSULE
brand · capsule, extended release
$4.90722 per EA filed
eff. 2026-09-23
$7.64418 per EA filed
Part D 2024 average
FOCALIN XR 20 MG CAPSULE
brand · capsule, extended release
$4.90695 per EA filed
eff. 2026-08-19 to 2026-09-30
$7.64418 per EA filed
Part D 2024 average
FOCALIN XR 25 MG CAPSULE
brand · capsule, extended release
$5.14314 per EA filed
eff. 2026-09-23
$7.64418 per EA filed
Part D 2024 average
FOCALIN XR 30 MG CAPSULE
brand · capsule, extended release
$4.74515 per EA filed
eff. 2026-09-23
$7.64418 per EA filed
Part D 2024 average
FOCALIN XR 35 MG CAPSULE
brand · capsule, extended release
$5.42512 per EA filed
eff. 2026-01-14
$7.64418 per EA filed
Part D 2024 average
FOCALIN XR 40 MG CAPSULE
brand · capsule, extended release
$5.42108 per EA filed
eff. 2026-09-23
$7.64418 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. between 2026-01-14 and 2026-09-30 (5 dates) · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 6 NDCs’ NADAC prices is $2.07153 per EA filed.

Of the 203 other products in FDA’s Central Nervous System Stimulant class priced per EA, 118 have a higher middle NADAC price and 85 a lower one. The one in the middle is FOCALIN XR 5 MG CAPSULE, at $4.70352 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $82.24 for 30 capsules, at an average of $2.74149 per EA in 2024 (2024-01-01 to 2024-12-31) for “Dexmethylphenidate HCl ER” and “Dexmethylphenidate HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 44,752 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for DEXMETHYLPHENIDATE ER 35 MG CP labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Dexmethylphenidate HCl ER / Dexmethylphenidate HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.